Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Martek

This article was originally published in The Tan Sheet

Executive Summary

Manufacturer of docosahexaenoic acid (DHA) products is test marketing a chewable form of the fatty acid beginning in early August, the company announces July 26. Martek currently markets the Neuromins DHA line, which includes a standard formula, Neuromins PL for pregnant and lactating women and an extension for children. The Columbia, Md.-based firm awaits an FDA response to its GRAS notification to add DHA to infant formula
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091508

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel